Loading...
XNYS
EVH
Market cap453mUSD
Dec 05, Last price  
3.94USD
1D
-1.75%
1Q
-59.00%
Jan 2017
-73.38%
IPO
-79.34%
Name

Evolent Health Inc

Chart & Performance

D1W1MN
XNYS:EVH chart
P/E
P/S
0.18
EPS
Div Yield, %
Shrs. gr., 5y
6.84%
Rev. gr., 5y
24.73%
Revenues
2.55b
+30.09%
8,346,00025,671,000096,878,000254,188,000434,950,000627,063,000846,383,0001,022,433,000907,957,0001,352,013,0001,963,896,0002,554,741,000
Net income
-62m
L-45.49%
-19,263,00020,023,000-25,246,000332,494,000-159,742,000-60,665,000-52,658,000-305,580,000-334,246,000-30,284,000-18,701,000-113,040,000-61,623,000
CFO
19m
-86.84%
-12,767,000-13,629,000-75,094,000-19,829,000-35,510,000-27,958,000-20,651,000-42,645,000-16,225,00038,747,000-11,553,000142,582,00018,765,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management. It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, population health performance that delivers patient-centric cost-effective care. The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology and cardiology; and holistic total cost of care improvement. The company was founded in 2011 and is headquartered in Arlington, Virginia.
IPO date
Jun 05, 2015
Employees
5,100
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT